Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Santacruzamate A

Inh 1477949-42-0 N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
N° du produit ABIN7233286
  • Application
    Inhibition (Inh)
    Fonction
    Ultrapotent HDAC2 inhibitor
    Attributs du produit
    A highly potent and selective inhibitor of HDAC2 isolated from the Panamanian marine cyanobacterium cf. Symploca (IC50=0.119 and 434 nM for HDAC2 and HDAC6 respectively). Induces apoptosis and cancer cell death only in combination with other HDAC1 inhibitors. Potential therapeutic agent for breast cancer. Attenuates Aβ fragment (Aβ25-35)-induced toxicity in PC12 cells by enhancing ER stress tolerance. Ameliorates Alzheimer's disease-like pathology in mouse models.
    Pureté
    >98 %
    Chemical Name
    N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
    Formula
    C15H22N2O3
    Solubility
    Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 20 mg/ml)
  • Restrictions
    For Research Use only
  • Format
    Powder
    Précaution d'utilisation
    GHS – Classification
    Not a hazardous substance
    Stock
    -20 °C
  • Sujet
    Epigenetics,Posttranslational modification,Protein deacetylase,Neuroscience,Cell death,Cellular stress,Cancer,Neurodegeneration,Apoptosis inducer,Chromatin
    Poids moléculaire
    278.35
    Numéro CAS
    1477949-42-0
Vous êtes ici:
Support technique